Market Exclusive

Analyst Activity – BMO Capital Markets Reiterates Sell on NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY)

Analyst Ratings For NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY)

Today, BMO Capital Markets reiterated its Sell rating on NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY) with a price target of $47.00.

Some recent analyst ratings include

Dividend information for NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY)

NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY) pays an annual dividend of $1.60 with a yield of 3.09% and an average dividend growth of 2.70% based on a 3 Year Average..

Dividend History for NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY)

Recent Insider Trading Activity For NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY)
NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY) has insider ownership of 0.23% and institutional ownership of 71.58%.

Recent Trading Activity for NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY)
Shares of NYSE:BMY – Bristol-Myers Squibb closed the previous trading session at 50.74 down -1.01 1.94% with shares trading hands.

Exit mobile version